[Association between the HLA system and myocardial infarct].

Area of Science:

• Cardiology
• Immunogenetics
• Endocrinology

Background:

• Myocardial infarction (MI) is a leading cause of mortality worldwide.
• The interplay between diabetes mellitus, hypertension, and cardiovascular disease is complex.
• Human Leukocyte Antigen (HLA) genes are known to influence immune responses and disease susceptibility.

Purpose of the Study:

• To investigate the association between specific Human Leukocyte Antigen (HLA) alleles and myocardial infarction (MI) in patients with and without diabetes mellitus and hypertension.
• To determine if concomitant diabetes and hypertension modify the genetic predisposition to MI.

Main Methods:

• A cohort of 200 patients with myocardial infarction was analyzed.
• Patients were stratified based on the presence or absence of insulin-independent diabetes mellitus and hypertension.
• HLA-BW antigen typing was performed for all participants.

Main Results:

• An association between the HLA-BW antigen and myocardial infarction was observed in patients with both diabetes and hypertension (35 patients).
• This specific association with HLA-BW was not detected in the subgroup of myocardial infarction patients without diabetes and hypertension (91 patients).
• The remaining 91 patients (MI without diabetes and hypertension) also did not show this association.

Conclusions:

• The presence of both diabetes mellitus and hypertension may be a critical factor in the observed association between HLA-BW and myocardial infarction.
• HLA-BW could play a role in the pathogenesis of myocardial infarction, particularly in patients with these metabolic and vascular comorbidities.
• Further research is warranted to elucidate the mechanisms underlying this genetic-comorbidity interaction in cardiovascular disease.